Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MMTEC Inc MTC

Technology Software - Application
Mmtec Inc is a China-based company primarily engaged in asset management services based on platforms. The Company is principally engaged in providing complete suite trading solutions, including fund creation, distribution, custody, trading and settlement services, to help these financial institutions accelerate their integration into overseas markets. The Company's systems include ETN counter... see more

Recent & Breaking News (NDAQ:MTC)

PENTAX Medical and Vedkang Establish Endoscopic Therapeutics Joint Venture

PR Newswire May 31, 2021

Canada House Wellness Group Announces Fulfillment of First Purchase Order to Cannabis NB

Canada NewsWire May 31, 2021

Kailo Medical Integrates with Medo AI to Standardize Thyroid Ultrasound Practices

Canada NewsWire May 31, 2021

PharmaCielo Appoints Experienced Cannabis Executive Ian D. Atacan as Chief Financial Officer

Canada NewsWire May 31, 2021

PharmaCielo Announces Financial Results for the First Quarter Ended March 31, 2021

Canada NewsWire May 31, 2021

RhoVac Confirms Forecast - BRaVac Phase IIb study recruitment to close in Quarter 3 2021

PR Newswire May 31, 2021

Braxia Scientific Appoints Dr. David Greenberg to Board of Directors

PR Newswire May 31, 2021

48North Cannabis Corp. Announces a revenue growth of 94% for Q3 2021

Canada NewsWire May 31, 2021

Covalon Announces Fiscal 2021 Q2 Results

Canada NewsWire May 31, 2021

Samsung Biologics to add mRNA vaccine drug substance manufacturing suite to expand portfolio of services

PR Newswire May 31, 2021

Hummingbird Bioscience Announces Publication of Abstract on Anti-VISTA Antibody HMBD-002 at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting

PR Newswire May 30, 2021

Nexturn Bio Inc. acquired a 50% stake in RosVivo Therapeutics, Inc.

PR Newswire May 30, 2021

Qynapse reaffirms its commitment to research in Multiple Sclerosis and is pleased to announce new projects to advance research and clinical care for MS patients

Canada NewsWire May 30, 2021

Tetra Bio-Pharma Announces Voting Results of 2021 Annual General and Special Meeting

Canada NewsWire May 28, 2021

Amgen To Present At The 2021 Jefferies Healthcare Conference

PR Newswire May 28, 2021

Natera Responds to Meritless Lawsuit and Files False Advertising Claim Against Guardant for Misleading Oncologists

PR Newswire May 28, 2021

Novartis reports one year results of Phase III MERLIN study evaluating BEOVU® every four week dosing and provides update on BEOVU clinical program

PR Newswire May 28, 2021

Halozyme to Present at Upcoming Investor Conferences

PR Newswire May 28, 2021

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Acadia Pharmaceuticals Inc. Investors With Losses Over $100K to Secure Counsel Before Important June 18 Deadline in Securities Class Action - ACAD

PR Newswire May 28, 2021

Liminal BioSciences Provides an Update on Currently Planned Clinical Activities for Fezagepras

Canada NewsWire May 28, 2021